Unknown

Dataset Information

0

Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study.


ABSTRACT:

Background

There is an urgent need to understand the real-world effectiveness of remdesivir in the treatment of SARS-CoV-2.

Methods

This was a retrospective comparative effectiveness study. Individuals hospitalized in a large private healthcare network in the US from February 23, 2020 through February 11, 2021 with a positive test for SARS-CoV-2 and ICD-10 diagnosis codes consistent with symptomatic COVID-19 were included. Remdesivir recipients were matched to controls using time-dependent propensity scores. The primary outcome was time to improvement with a secondary outcome of time to death.

Results

Of 96,859 COVID-19 patients, 42,473 (43.9%) received at least one remdesivir dose. The median age of remdesivir recipients was 65 years, 23,701 (55.8%) were male and 22,819 (53.7%) were non-white. Matches were found for 18,328 patients (43.2%). Remdesivir recipients were significantly more likely to achieve clinical improvement by 28 days (adjusted hazard ratio [1.19, 95% confidence interval (CI), 1.16-1.22]). Remdesivir patients on no oxygen (aHR 1.30, 95% CI 1.22-1.38) or low-flow oxygen (aHR 1.23, 95% CI 1.19-1.27) were significantly more likely to achieve clinical improvement by 28 days. There was no significant impact on the likelihood of mortality overall (aHR 1.02, 95% CI 0.97-1.08). Remdesivir recipients on low-flow oxygen were significantly less likely to die than controls (aHR 0.85, 95% CI 0.77-0.92; 28-day mortality 8.4% [865 deaths] for remdesivir patients, 12.5% [1,334 deaths] for controls).

Conclusions

These results support the use of remdesivir for hospitalized COVID-19 patients on no or low-flow oxygen. Routine initiation of remdesivir in more severely ill patients is unlikely to be beneficial.

SUBMITTER: Garibaldi BT 

PROVIDER: S-EPMC8754724 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7745180 | biostudies-literature
| S-EPMC10684838 | biostudies-literature
| S-EPMC8856900 | biostudies-literature
| S-EPMC9533997 | biostudies-literature
| S-EPMC8477891 | biostudies-literature
| S-EPMC9384598 | biostudies-literature
| S-EPMC9821121 | biostudies-literature
| S-EPMC6064583 | biostudies-literature
| S-EPMC8372837 | biostudies-literature
| S-EPMC9059224 | biostudies-literature